Literature DB >> 6884392

Lactic acidosis, neurological deterioration and compromised cellular pyruvate oxidation due to a defect in the reoxidation of cytoplasmically generated NADH.

B H Robinson, J Taylor, B Francois, A L Beaudet, D F Peterson.   

Abstract

Two patients, one dying at 25 days and one at 20 months had 'chronic' lactic acidaemia with a high lactate to pyruvate ratio. Both showed EEG abnormalities and seizure activity and both died of respiratory failure. Investigation of cultured skin fibroblasts from these patients revealed normal pyruvate dehydrogenase and pyruvate carboxylase activities but the cells showed a decreased ability to oxidase pyruvate which was returned to normal on the addition of methylene blue. Subsequent investigations revealed that the mitochondria from the patients' cells could oxidase pyruvate normally but that the cells had an abnormal NAD to NADH ratio under standard conditions of incubation. It was concluded that both children had a redox disequilibrium in the cytoplasmic compartment due to a problem in transporting reducing equivalents from the cytoplasmic to the mitochondrial compartments.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6884392     DOI: 10.1007/bf00441651

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  13 in total

1.  Glucose-6-phosphatase deficiency glycogen storage disease. Studies on the interrelationships of carbohydrate, lipid, and purine abnormalities.

Authors:  R R HOWELL; D M ASHTON; J B WYNGAARDEN
Journal:  Pediatrics       Date:  1962-04       Impact factor: 7.124

2.  Leigh's encephalomyelopathy in a patient with cytochrome c oxidase deficiency in muscle tissue.

Authors:  J L Willems; L A Monnens; J M Trijbels; J H Veerkamp; A E Meyer; K van Dam; U van Haelst
Journal:  Pediatrics       Date:  1977-12       Impact factor: 7.124

3.  Hepatic fructose-1,6-diphosphatase deficiency. A cause of lactic acidosis and hypoglycemia in infancy.

Authors:  A S Pagliara; I E Karl; J P Keating; B I Brown; D M Kipnis
Journal:  J Clin Invest       Date:  1972-08       Impact factor: 14.808

4.  Lactic acidosis due to pyruvate carboxylase deficiency.

Authors:  J C Haworth; B H Robinson; T L Perry
Journal:  J Inherit Metab Dis       Date:  1981       Impact factor: 4.982

5.  Pyruvate dehydrogenase phosphatase deficiency: a cause of congenital chronic lactic acidosis in infancy.

Authors:  B H Robinson; W G Sherwood
Journal:  Pediatr Res       Date:  1975-12       Impact factor: 3.756

6.  Pyruvate carboxylase and phosphoenolpyruvate carboxykinase activity in leukocytes and fibroblasts from a patient with pyruvate carboxylase deficiency.

Authors:  B M Atkin; M F Utter; M B Weinberg
Journal:  Pediatr Res       Date:  1979-01       Impact factor: 3.756

7.  Growth of human diploid fibroblasts in the absence of glucose utilization.

Authors:  H R Zielke; P T Ozand; J T Tildon; D A Sevdalian; M Cornblath
Journal:  Proc Natl Acad Sci U S A       Date:  1976-11       Impact factor: 11.205

8.  A defect in pyruvate decarboxylase in a child with an intermittent movement disorder.

Authors:  J P Blass; J Avigan; B W Uhlendorf
Journal:  J Clin Invest       Date:  1970-03       Impact factor: 14.808

9.  Transport of reduced nicotinamide-adenine dinucleotide into mitochondria of rat white adipose tissue.

Authors:  B H Robinson; M L Halperin
Journal:  Biochem J       Date:  1970-01       Impact factor: 3.857

10.  The genetic heterogeneity of lactic acidosis: occurrence of recognizable inborn errors of metabolism in pediatric population with lactic acidosis.

Authors:  B H Robinson; J Taylor; W G Sherwood
Journal:  Pediatr Res       Date:  1980-08       Impact factor: 3.756

View more
  8 in total

1.  Treatment of chronic congenital lactic acidosis by oral administration of dichloroacetate.

Authors:  Y Kuroda; M Ito; K Toshima; E Takeda; E Naito; T J Hwang; T Hashimoto; M Miyao; M Masuda; K Yamashita
Journal:  J Inherit Metab Dis       Date:  1986       Impact factor: 4.982

2.  Treatment of congenital lactic acidosis with dichloroacetate.

Authors:  P W Stacpoole; C L Barnes; M D Hurbanis; S L Cannon; D S Kerr
Journal:  Arch Dis Child       Date:  1997-12       Impact factor: 3.791

Review 3.  Therapy of mitochondrial disorders.

Authors:  H Przyrembel
Journal:  J Inherit Metab Dis       Date:  1987       Impact factor: 4.982

4.  Respiratory chain defects in the mitochondria of cultured skin fibroblasts from three patients with lacticacidemia.

Authors:  B H Robinson; J Ward; P Goodyer; A Baudet
Journal:  J Clin Invest       Date:  1986-05       Impact factor: 14.808

5.  Defective intramitochondrial NADH oxidation in skin fibroblasts from an infant with fatal neonatal lacticacidemia.

Authors:  B H Robinson; N McKay; P Goodyer; G Lancaster
Journal:  Am J Hum Genet       Date:  1985-09       Impact factor: 11.025

6.  Lactic acidaemia.

Authors:  B H Robinson; W G Sherwood
Journal:  J Inherit Metab Dis       Date:  1984       Impact factor: 4.982

7.  Deficiency of the iron-sulfur clusters of mitochondrial reduced nicotinamide-adenine dinucleotide-ubiquinone oxidoreductase (complex I) in an infant with congenital lactic acidosis.

Authors:  R W Moreadith; M L Batshaw; T Ohnishi; D Kerr; B Knox; D Jackson; R Hruban; J Olson; B Reynafarje; A L Lehninger
Journal:  J Clin Invest       Date:  1984-09       Impact factor: 14.808

8.  Genome-wide association analysis identifies a mutation in the thiamine transporter 2 (SLC19A3) gene associated with Alaskan Husky encephalopathy.

Authors:  Karen M Vernau; Jonathan A Runstadler; Emily A Brown; Jessie M Cameron; Heather J Huson; Robert J Higgins; Cameron Ackerley; Beverly K Sturges; Peter J Dickinson; Birgit Puschner; Cecilia Giulivi; G Diane Shelton; Brian H Robinson; Salvatore DiMauro; Andrew W Bollen; Danika L Bannasch
Journal:  PLoS One       Date:  2013-03-04       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.